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Rats of the Wistar Albino Glaxo/Rij (WAG/Rij) strain show symptoms resembling
human absence epilepsy. Thalamocortical neurons of WAG/Rij rats are characterized
by an increased HCN1 expression, a negative shift in Ih activation curve, and an
altered responsiveness of Ih to cAMP. We cloned HCN1 channels from rat thalamic
cDNA libraries of the WAG/Rij strain and found an N-terminal deletion of 37 amino
acids. In addition, WAG-HCN1 has a stretch of six amino acids, directly following
the deletion, where the wild-type sequence (GNSVCF) is changed to a polyserine
motif. These alterations were found solely in thalamus mRNA but not in genomic
DNA. The truncated WAG-HCN1 was detected late postnatal in WAG/Rij rats and
was not passed on to rats obtained from pairing WAG/Rij and non-epileptic August
Copenhagen Irish rats. Heterologous expression in Xenopus oocytes revealed 2.2-fold
increased current amplitude of WAG-HCN1 compared to rat HCN1. While WAG-HCN1
channels did not have altered current kinetics or changed regulation by protein kinases,
fluorescence imaging revealed a faster and more pronounced surface expression of
WAG-HCN1. Using co-expression experiments, we found that WAG-HCN1 channels
suppress heteromeric HCN2 and HCN4 currents. Moreover, heteromeric channels of
WAG-HCN1 with HCN2 have a reduced cAMP sensitivity. Functional studies revealed
that the gain-of-function of WAG-HCN1 is not caused by the N-terminal deletion
alone, thus requiring a change of the N-terminal GNSVCF motif. Our findings may
help to explain previous observations in neurons of the WAG/Rij strain and indicate
that WAG-HCN1 may contribute to the genesis of absence seizures in WAG/Rij
rats.
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INTRODUCTION
Alterations in HCN channel expression and the corresponding
pacemaker current Ih were attributed to pathological activity in
the thalamocortical (TC) system, like SWD which are typical for
childhood absence epilepsy (Budde et al., 2005; Kuisle et al., 2006;
Biel et al., 2009; Kanyshkova et al., 2012). Several animal models
were used to determine concepts of SWD generation (Crunelli
and Leresche, 2002; Coenen and van Luijtelaar, 2003; Pinault and
O’Brien, 2005; van Luijtelaar and Sitnikova, 2006; Huguenard
and McCormick, 2007; Leresche et al., 2012). In WAG/Rij, SWD
seem to start from the SSC, quickly spreading over the cortex, and
invade the thalamus which provides a resonance circuitry for the
ampliﬁcation, spreading and entrainment (van Luijtelaar et al.,
2011a,b; Lüttjohann and van Luijtelaar, 2015).
In WAG/Rij rats, systemic injections of Ih blockers resulted
in a dose-dependent decrease in SWD pointing to a crucial
role of HCN channels (van Luijtelaar et al., 2011b; van
Luijtelaar and Zobeiri, 2014). Especially changed functionality
of HCN1 channels with diﬀerent characteristics in thalamus
and cortex is involved in the increased seizure susceptibility
(Ludwig et al., 2003; Strauss et al., 2004; Budde et al., 2005;
Schridde et al., 2006; Kole et al., 2007; Kanyshkova et al.,
2012). In the cortex, a reduction of HCN1 expression increases
somato-dendritic excitability of pyramidal neurons leading to
pathologically synchronized membrane currents and in turn
to seizures (Strauss et al., 2004; Kole et al., 2007; Kanyshkova
et al., 2012). Pharmacological treatment that prevents SWD
also prevents the down-regulation of HCN1 in cortical areas
of WAG/Rij rats (Blumenfeld et al., 2008). In the thalamus,
the expression of HCN1 was higher in WAG/Rij rats than in
non-epileptic rat strains (Budde et al., 2005; Kanyshkova et al.,
2012). This change was accompanied by an increased Ih current
density, a negative shift of the activation curve of Ih, and a
decreased sensitivity of Ih to cAMP in TC neurons which might
result in an impairment to control the shift from burst to
tonic ﬁring. Furthermore an increase in thalamic expression of
TRIP8b, an HCN channel ancillary subunit, was found (Lewis
et al., 2009; Santoro et al., 2009; Zolles et al., 2009), coinciding
with the more negative voltage dependence of Ih activation
present in WAG/Rij TC neurons. In order to ﬁnd possible
evidence for speciﬁc changes in the HCN1 channel protein
and an explanation for the opposite direction of altered HCN1
expression in thalamus versus cortex of the WAG/Rij strain,
we cloned HCN1 from the thalamus of WAG/Rij rats. Here,
we identiﬁed a HCN1 variant with an N-terminal deletion in
the WAG/Rij rat strain which we named WAG-HCN1. We
have functionally characterized WAG-HCN1 by heterologous
expression and revealed a possible contribution of this HCN1
Abbreviations: ACI, August Copenhagen Irish rat; dLGN, dorsal part of the
lateral geniculate nucleus; HCN, hyperpolarization-activated cyclic nucleotide-
gated cation channel; Ih, hyperpolarization-activated inward current; P, postnatal
day; SSC, somatosensory cortex; SWD, spike-and-wave discharge; TC neuron,
thalamocortical relay neuron; TEVC, two-electrode voltage clamp; TRIP8b,
tetratricopeptide repeat-containing Rab8b-interacting protein; WAG/Rij, Wistar
Albino Glaxo rats from Rijswijk.
variant to the generation of absence epilepsy present in the
WAG/Rij strain.
MATERIALS AND METHODS
Full-length HCN1 Cloning
Total RNA was prepared from freshly dissected tissue by
extraction with Trizol reagent according to the instructions of the
manufacturer (RNeasy Lipid Tissue, Qiagen). Integrated QIAzol
and RNeasy technologies of this Kit eﬃciently remove most of
the DNA without DNase treatment. However, we used additional
DNAseI digestions to remove also very small amounts of DNA.
First-strand cDNA was primed with random hexamer primers
(Invitrogen Life Technologies) from 0.5 to 1 μg of RNA and
synthesized using the SuperScript II enzyme (Invitrogen) at
42◦C for 50 min. Full-length cDNA for rat HCN1 and WAG-
HCN1 were obtained by reverse transcription-polymerase chain
reaction (RT-PCR) from total thalamic RNA. Three WAG/Rij
rats from diﬀerent oﬀspring were used with three diﬀerent
DNA Taq polymerases: HS DNA Taq polymerase (TAKARA),
HF2 DNA Taq polymerase (Clontech) and Pfu Turbo DNA Taq
polymerase (Stratagene). Primers were as follows: forward, TTG
GCCTCAAGCCCCCGGCGAGTCT; reverse, TCATAAATT
CGA AGC AAA ACG GGG TTT (NM_053375, nucleotides 15–
2807). PCR products corresponding to the full-size rat HCN1
were puriﬁed by agarose gel electrophoresis and cloned into
pGEM-TEasy vector. Following bacteria transformation, clones
containing HCN1 and WAG-HCN1 constructs were observed
from all three cDNA preparations. All cDNA constructs for both
HCN1 and WAG-HCN1 were established by sequencing of at
least 10 diﬀerent full-length cDNA clones for each preparation.
For live cell imaging rat HCN1 andWAG-HCN1were subcloned
in the pEGFP-N vector (Clontech).
Preparation of Genomic DNA
Preparation of genomic DNA (gDNA) was carried out by
transfering small tissue samples from rat tails in lysis reagent
(DirectPCR Tail, Peqlab) containing proteinase K (0.25 mg/mL).
Tissue was incubated for 4 h at 55◦C in a rotating hybridization
oven followed by 45 min at 85◦C in a thermomixer and short
centrifugation. Small samples of lysate (1–1.5 μL) were used as
template for PCR.
Reverse Transcription-polymerase Chain
Reaction
First-strand cDNAs were prepared as described above.
Normalization was carried out against an endogenous
housekeeping gene transcript for ß-actin. PCR was performed in
a 20 μl reaction mixture using 0.5 U Taq polymerase (Qiagen);
mixture in all cases contained 1.5 mM MgCl2, 0.2 mM of each
dNTP, and 20 pmol of each primer using following cycling
protocol: 3 min at 94◦C; 35 cycles (25 cycles in case of ß-
actin): 30 s at 94◦C, 1 min at Tann, 1 min at 72◦C; with a ﬁnal
elongation for 7 min at 72◦C. The following primers were used:
ß-actin, forward, ATT TGG CAC CAC ACT TTC TAC AAT,
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reverse, CTG CTT GCT GAT CCA CAT CTG C (NM_031144,
nucleotides 253–1080), Tann was 54◦C; HCN1, forward, GCC
TCA AGC CCC CGG CGA GTC T, reverse, ACG ATC CGA
AGT GCT CTG GCG GTC TTG TAA (NM_053375, nucleotides
18–811), Tann = 65◦C.
Semi-quantitative RT-PCR
All measurements for the relative comparison of HCN1 and
WAG-HCN1 expression levels were performed within the
exponential phase of PCR ampliﬁcation. The optimal number
of cycles required for detection of products in the linear
range of ampliﬁcation was determined for each of the cDNA-
primer pair combinations in preliminary experiments. The
level of mRNAs from WAG/Rij, ACI, WAG/Rji x ACI, and
ACI x WAG/Rji rat tissues was normalized to each other
using the constitutively expressed housekeeping gene β-actin.
Quantiﬁcation of each gene was achieved by the densitometric
analysis of PCR products followed by calculation of the
expression diﬀerence determined as a ratio of the PCR product of
HCN1 to the PCR product of WAG-HCN1 using ImageJ (NIH,
Bethesda).
Expression of HCN Channels in Xenopus
oocytes
Xenopus oocytes were prepared as previously described (Streit
et al., 2011). Brieﬂy, isolated oocytes were stored at 18◦C in
ND96 recording solution containing in mM: NaCl 96, KCl 2,
CaCl2 1.8, MgCl2 1, HEPES 5; pH 7.4 with NaOH, supplemented
with Na-pyruvate (275 mg/l), theophylline (90 mg/l), and
gentamicin (50 mg/l). WAG-HCN1 and rat HCN1 were
subcloned in pSGEM, linearized with NheI and cRNA was made
using T7 polymerase. mHCN2 and hHCN4 were subcloned
in pBF1. The mHCN2 construct was linearized with Eco72I
and hHCN4 cDNA was linearized with Ade1. For in vitro
transcription of HCN2 and HCN4 SP6 polymerase was used.
Stages IV and V oocytes were injected with 5 ng of rat
HCN1 or WAG-HCN1 cRNA. For co-expression, we used
5 ng HCN1 cRNA plus either 10 ng mouse HCN2, 25 ng
human HCN4 or 1.25 ng human Kv1.1 cRNA, synthesized
using the mMESSAGE mMACHINE Kit (Ambion). Standard
TEVC experiments were performed at room temperature (21–
22◦C) in ND96 recording solution 2 days after the cRNA
injection. Microelectrodes were fabricated from glass capillary
tubes and ﬁlled with 3 M KCl. Tip resistance was in the
range of 0.3–1.0 M. TEVC recordings were performed using
a TurboTEC-10CD Ampliﬁer (npi) with a Digidata 1200 A/D-
converter (Axon Instruments). For data acquisition the software
pCLAMP7 (Axon Instruments) was used and data were analyzed
with ClampFit10 (Axon Instruments). As current amplitudes
after injection of a speciﬁc amount of cRNA varies from
batch to batch, the current change by WAG-HCN1 from a
batch of oocytes/experiments was normalized to the wild-type
current. The ‘relative current’ provides the average current
change analyzed from several batches of oocytes. This analysis
more accurately reﬂects the current change that is observed
in each individual batch of experiment, as it eliminates the
ﬂuctuations in overall expression levels (batch variance of
amplitudes).
Drugs
H-89, staurosporine, bisindolylmaleimide (all Cell Signaling
Technology) and genistein (Sigma-Aldrich) were prepared from
stock solution stored in DMSO and diluted in ND96 prior
to recording. DMSO concentration was kept below 0.1% of
the ﬁnal solution. 8-Br-cAMP (Biaﬃn GmbH & Co KG)
was directly diluted in ND96 recording solution prior to
measurements.
Animal Experiments
All animal experiments were carried out in accordance with
EU Directive 2010/63/EU for animal experiments. The protocol
was approved by the local animal care committee of the
Regierungspräsidium Gießen.
Statistics
All currents have been quantiﬁed at a potential of steady-
state activation (−130 mV), unless stated otherwise. Results are
reported as mean ± SEM (n = number of cells). Statistical
diﬀerences were evaluated using an unpaired Student’s t-test,
unless stated otherwise. Signiﬁcance was assumed for ∗p < 0.05;
∗∗p < 0.01; ∗∗∗p < 0.001 and “n.s.” indicates a non-signiﬁcant
change.
RESULTS
Rats of the WAG/Rij Strain Express an
N-terminal Deletion Variant of HCN1
(WAG-HCN1)
Rats of the strain WAG/Rij typically show symptoms of absence-
like epilepsy (van Luijtelaar and Sitnikova, 2006). Our aim
was to analyze the contribution of HCN channel genes to
this phenotype. While cloning of HCN1 channels from cDNA
libraries obtained from thalamus of adult rats, we observed that
the HCN1 channel from WAG/Rij rats harbors an N-terminal
deletion (Figure 1). This deletion variant (WAG-HCN1) was
only observed in thalamic cDNA libraries of epileptic rats
(Figure 1C), but not in cDNA of the non-epileptic control strain
ACI (Figure 1C, lower panel). An alignment with the Rattus
norvegicus HCN1 mRNA (NM_053375) revealed a deletion of
111 bases and several base exchanges in the N-terminal region
(Figure 1A). Sequencing of genomic DNA from the thalamus
of WAG/Rij rats revealed that this deletion was not present
on chromosome 2 when compared to the genomic sequence
of Rattus norvegicus (NW_047620; Figure 1B). A PCR analysis
using speciﬁc primers of the N-terminal region generated two
bands with the expected length of 794 basepairs (HCN1) and
683 basepairs (WAG-HCN1) in samples from two thalamic
areas (dLGN, VB) but not from hippocampus (Hippo) and
primary SSC (Figure 1C, upper panel). In order to explore
the hereditary of the WAG-HCN1 trait, we bred WAG/Rij
with the corresponding non-epileptic strain (Depaulis and van
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FIGURE 1 | Distribution of WAG-HCN1 channel in rat brain tissues. (A) Alignment of the N-terminus of the mRNA sequences from rat HCN1 and WAG-HCN1.
The WAG-HCN1 mRNA has a deletion of 111 nucleotides, and 10 nucleotides following the deletion are exchanged (gray letters and boxes). The sequences
displayed are integral parts of exon 1 of rat HCN1. (B) Alignment of the genomic sequences corresponding to the N-terminal mRNA of rat HCN1 and WAG-HCN1
displayed in (A). No differences were found (n = 5). (C) Upper panel, RT-PCR detection of HCN1 and WAG-HCN1 in different rat brain tissues: dLGN, ventrobasal
thalamic complex (VB), hippocampus (Hippo), and S1 region of SSC. An additional PCR experiment of the dLGN with an expanded view of the double bands is
illustrated in the middle (box). Lower panel, comparison of PCR detection of HCN1 and WAG-HCN1 (same experiment as the expanded view) in the LGN of WAG/Rij
versus ACI rat after 27, 29, and 31 cycles. (D) RT-PCR detection of HCN1 using dLGN cDNA obtained from breaded WAG/Rij (W) and ACI (A) rats (♀ WAG/Rij x ♂
ACI and ♀ ACI x ♂ WAG/Rij, correspondingly). (E) PCR analysis of HCN1 and WAG-HCN1 isoforms in rat genomic DNA of WAG/Rij, ACl and their offspring.
(F,G) Semi-quantitative RT-PCR analysis of HCN1 and WAG-HCN1 in the dLGN regions of WAG/Rij rats of different ages (P7, P30, P90). (F) Gel images of RT-PCR
at P7. The numbers of PCR cycles are indicated. (G) Analysis of the peak intensities for PCR signals were plotted against cycle numbers for HCN1 and WAG-HCN1
at P7, P30 and P90. (C–G) The number of independent animals was n = 4 for all conditions.
Luijtelaar, 2006), the ACI rats (♀WAG/Rij x ♂ ACI; ♀ ACI x ♂
WAG/Rij). While the WAG-HCN1 PCR band was detected in all
dLGN tissue samples from WAG/Rij rats (collected over many
generations from 2005 to 2012), no positive PCR signals were
found inWAG/Rij-ACI hybrids (two litters with a total of 16 pups
were analyzed; Figure 1D). As for WAG/Rij and ACI rats, no
PCR signals of theWAG-HCN1 variant were found inWAG/Rij-
ACI hybrids using genomic DNA as template (Figure 1E).
Next, we assessed the developmental expression level of WAG-
HCN1 using cDNA from dLGN at P7, P30, and P90. Due to
the high GC-content of the HCN1 N-terminus, we could not
design primers suitable for a quantitative real time PCR analysis
of the two variants. Thus, the expression levels were analyzed
using a semi-quantitative PCR approach and peak densitometry
of the gel bands (Figures 1F,G). While WAG-HCN1 was not
detected at P7 (Figures 1F,G), the WAG-HCN1 variant was
up-regulated at postnatal ages P30 and P90 (Figure 1G). Note
that the relative amount of WAG-HCN1 mRNA identiﬁed
here appeared very small, with only approximately 10% of the
transcripts.
The WAG-HCN1 Deletion Leads to
Increased HCN1 Current Amplitudes
(Gain-of-function) While Gating Behavior
of the Channel Remains Unaltered
Figure 2A illustrates an alignment of Rattus norvegicus HCN1
and WAG-HCN1 N-terminal protein sequences. The sequence
of the WAG-HCN1 channel lacks 37 amino acids in the proximal
N-terminus of the channel. In addition, WAG-HCN1 has a
stretch of six amino acids, directly following the deletion, where
the wild-type sequence GNSVCF is changed to a polyserine motif
(Figure 2A). Next, we analyzed the functional diﬀerences caused
by the altered N-terminus by electrophysiological recordings
using the Xenopus oocyte expression system. Expression of
WAG-HCN1 in oocytes yields the typical fast activating HCN1
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FIGURE 2 | Electrophysiological characterization of the WAG-HCN1 channel. (A) Alignment of the first 60 amino acids of the N-terminus from rat HCN1 and
WAG-HCN1. The WAG-HCN1 channels have a deletion of 37 amino acids and six amino acids directly following the deletion (GNSVCF) are exchanged to serine
residues. (B) Representative measurements of HCN1 (top) and WAG-HCN1 (bottom) currents. Oocytes were held at −30 mV and voltage steps of 2 s ranging from
−30 to −140 mV were applied, followed by a step to −130 mV to record tail currents, see the illustrated voltage protocol. (C) Comparison of current amplitude of
HCN1 (black), WAG-HCN1 (gray) and heteromeric HCN1/WAG-HCN1 currents (light gray), analyzed at −130 mV. The number of experiments are indicated in the
bar graphs. (D) Conductance-voltage relationships of HCN1 (black), WAG-HCN1 (gray) and heteromeric HCN1/WAG-HCN1 currents (light gray). (E) Slow and fast
time constants of activation at three different potentials, analyzed for HCN1 (black) and WAG-HCN1 (gray) using a bi-exponential fit. Right panel illustrates the
amplitude ratio of the fast component over the sum of the fast and slow component. The number of experiments are indicated in the bar graphs. (F) Slow and fast
time constants of deactivation analyzed at +20 mV for HCN1 (black) and WAG-HCN1 (gray) using bi-exponential fits. Right panel illustrates the amplitude ratio of the
fast component of deactivation over the sum of the fast and slow component. The number of experiments are indicated in the bar graphs. ∗∗∗p < 0.001.
currents (Figure 2B) upon hyperpolarization of the plasma
membrane. Interestingly, the currents after injection of a
WAG-HCN1 construct were larger than rat HCN1 currents
(Figures 2B,C). After 48 h of expression, the WAG-HCN1
currents were by a factor of 2.19 ± 0.13 (n = 78) larger
than rat HCN1 currents (1.00 ± 0.05, n = 77; Figure 2C).
Co-expression of WAG-HCN1 with rat HCN1 also increased
current amplitudes, albeit to a lesser extent (Figure 2C).
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As co-expression of WAG-HCN1 with rat HCN1 (n = 26)
yielded currents with an intermediate amplitude of 1.40 ± 0.07
(n = 26; Figure 2C), we conclude that the increased current
amplitude is not transduced to the heteromeric channel in a
dominant-active manner. The voltage dependence of activation
of rat HCN1, WAG-HCN1 and the heteromeric channels
were not altered (Figure 2D). The voltage of half-maximal
activation (V1/2) was −62.59 ± 0.49 mV (n = 37) for
rat HCN1, −60.21 ± 0.69 mV (n = 35) for WAG-HCN1,
and −58.69 ± 0.66 mV (n = 20) for the heteromeric
channels. Next, we analyzed the activation (Figure 2E) and
deactivation kinetics (Figure 2F) of WAG-HCN1 channels.
Activation kinetics of HCN1 and WAG-HCN1 currents were
analyzed in the voltage range of −110 to −130 mV, using
bi-exponential ﬁts (Figure 2E). The relative amplitudes of
the fast and slow component of activation are shown in
Figure 2E as a ratio of fast component over the sum of
both components (right panel, n = 6 each). We found that
the activation kinetics were similar for rat HCN1 and WAG-
HCN1. Analyzing the kinetics of deactivation at +20 mV,
using bi-exponential ﬁts, we found that also the deactivation
kinetic of WAG-HCN1 is not altered in comparison to
rat HCN1 (Figure 2F). Summarizing, WAG-HCN1 channels
produce about 2.2-fold more current than rat HCN1 channels,
without any apparent changes in voltage dependence, as well
as activation and deactivation kinetics. Preliminary ﬂuorescence
imaging experiments indicate that WAG-HCN1 channels have
an increased surface expression, while Western blot experiments
with COS7 cells transfected with either HCN1 or WAG-HCN1
revealed that the global protein expression of HCN1 and WAG-
HCN1 were similar (data not shown). In summary, given also
the unaltered current characteristics (gating properties) ofWAG-
HCN1, our data suggests an increased surface expression as
a mechanism (Figures 2D–F) for the increased WAG-HCN1
current amplitudes (Figure 2C).
Co-expression with WAG-HCN1 Reduces
Current Amplitudes of Other HCN Family
Members
HCN1 channels are mainly expressed in the brain, where they
can heteromerize with diﬀerent HCN isoforms to form functional
channels (Chen et al., 2001; Much et al., 2003). Therefore, we
characterized the WAG-HCN1 variant also by co-expressions
with other HCN family members, expressed in TC neurons.
For co-expression, oocytes were injected with 5 ng of HCN1
cRNA together with 10 ng of HCN2 or 25 ng of HCN4
cRNA. The amounts of cRNAs were previously determined in
order that every channel generates similar current amplitudes
when injected alone (data not shown). The most interesting
and somewhat unexpected observation was that co-expressions
of WAG-HCN1 with either HCN2 or HCN4 yielded reduced
current amplitudes of the heteromeric channels (Figures 3A–C).
WhenWAG-HCN1 was co-expressed with HCN2, currents were
reduced by 45% in comparison to the co-expression with rat
HCN1 (n = 48; Figures 3A,B). Co-expression of WAG-HCN1
with HCN4 led to an even more pronounced reduction of
current amplitudes. Heteromeric HCN1/HCN4 currents were
reduced by 57% due to the presence of WAG-HCN1 (n = 36;
Figure 3C). Note that the current reduction of HCN2 or HCN4
by WAG-HCN1 are most likely, due to the low expression
levels of WAG-HCN1, less pronounced than observed in these
experiments.
As a control, we have co-expressed Kv1.1 with either HCN1
or WAG-HCN1 and analyzed the Kv1.1 current amplitudes
(Figure 3D). The fact that the Kv1.1 current amplitudes are not
suppressed by co-expression with WAG-HCN1 further supports
that the HCN2 or HCN4 current reduction are not caused
by a limited protein translation eﬃciency due to the increased
expression levels of WAG-HCN1. These ﬁndings indicate
that WAG-HCN1 directly interacts with HCN2 or HCN4
FIGURE 3 | Co-expression of HCN1 or WAG-HCN1 with other HCN family members. (A) Representative current traces of the co-expression of HCN1 or
WAG-HCN1 with HCN2. (B) Co-expression with WAG-HCN1 causes a significant decrease in current amplitude analyzed at −130 mV. The number of experiments
are indicated in the bar graphs. (C) Co-expression of WAG-HCN1 with HCN4 shows a significant decrease in current amplitude analyzed at −130 mV. The number
of experiments are indicated in the bar graphs. (D) Relative current amplitudes (at +40 mV) for Kv1.1 after co-expression with HCN1 or WAG-HCN1 with HCN2. The
number of experiments are indicated in the bar graphs. ∗∗∗p < 0.001.
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to decrease currents encoded by the respective heteromeric
channels.
WAG-HCN1/HCN2 Heteromers have a
Reduced cAMP Sensitivity
Hyperpolarization-activated inward current from TC neurons
has a strong contribution of HCN2 channels (Ludwig et al.,
2003; Kanyshkova et al., 2009). As the Ih current in TC neurons
of the rat WAG/Rij strain has an altered voltage dependence
of activation and cAMP-responsiveness (Budde et al., 2005;
Kanyshkova et al., 2012), we studied the heteromeric channels
of WAG-HCN1 with HCN2 in more detail. As described above,
for co-expression oocytes were co-injected with 5 ng HCN1 or
WAG-HCN1 cRNA and 10 ng HCN2 cRNA. Current-voltage
relationship of heteromeric channels of HCN2 together with
WAG-HCN1was not signiﬁcantly altered (Figures 4A–C).While
channels from a co-expression of HCN2 with HCN1 had a
V1/2 of activation of −62.3 ± 1.0 mV (n = 6), heteromeric
channels with WAG-HCN1 had a V1/2 of −60.0 ± 1.7 mV
(n = 7; Figures 4A–C). Next we aimed to analyze whether
there was an altered cAMP-responsiveness of heteromeric WAG-
HCN1/HCN2 channels. In general, the activation curve of HCN1
is more depolarized than for the other HCN family members
and additional application of cAMP aﬀects the activation curve
only marginally. The reason for this eﬀect is that at typical
basal concentrations of cAMP in neurons, HCN1 channels are
not inhibited by the C-linker/CNBD region and already reveal
a right shifted position of the activation curve (Lolicato et al.,
2011; Chow et al., 2012). Therefore, for the recordings with 8-
Br-cAMP, theophylline was omitted from the storage solution,
to have the lowest possible cAMP levels. Measurements were
made before and after 5 min of incubation with 2 mM 8-Br-
cAMP. Application of 2 mM 8-Br-cAMP signiﬁcantly shifted
the activation of heteromeric HCN1/HCN2 channels (V1/2)
by +2.3 mV (n = 6; Figures 4A,C). The rather small eﬀect of
8-Br-cAMP on HCN1/HCN2 channels in the oocyte expression
system might be due to the still high cAMP levels present in
whole cell oocytes which may be already close to the maximally
possible cAMP shift. Thus, only small additional shifts can be
achieved by 8-Br-cAMP. Similar small cAMP responses in whole
cell oocytes were observed for homomeric HCN1 and HCN2
channels alone (data not shown). Most importantly, 2 mM 8-Br-
cAMP did not cause a signiﬁcant shift in the V1/2 of heteromeric
WAG-HCN1/HCN2 channels (V1/2 = −0.6 mV; n = 7;
Figures 4B,C).
The Polyserine Motif Present in the
WAG-HCN1 N-terminus does not Cause
the HCN Current Gain-of-function
As mentioned above, a comparison of the protein sequence
of rat HCN1 channels with that of WAG-HCN1 shows that
there are two major diﬀerences in the N-terminal segment of
the HCN1 channel. First, there is a deletion of 37 amino acids
in the proximal N-terminus of the WAG-HCN1 variant and
second, there is a stretch of six amino acids following the
deletion which is altered to a polyserine-motif (Figure 5A). An
increased phosphorylation of channels at the polyserine motif
might cause an increased surface traﬃcking or an altered gating.
We checked for diﬀerences in the phosphorylation dependent
modulation ofHCN1 andWAG-HCN1utilizing diﬀerent protein
kinase inhibitors. Bisindolylmaleimide I (1 μM) was used to
inhibit protein kinase C (Davis et al., 1989) and H-89 (1 μM) to
block cAMP dependent protein kinase A (Chijiwa et al., 1990).
Genistein (10 μM) was tested as a blocker of tyrosine kinases
(Akiyama et al., 1987). Finally, staurosporine (1 μM), which is
also known to induce cell apoptosis (Couldwell et al., 1994; Yue
et al., 1998), was used as an unspeciﬁc kinase inhibitor, aﬀecting
PKA, PKC, PKG, CAMKII and myosin light chain kinase (Ruegg
and Burgess, 1989). Oocytes were injected with either HCN1 or
WAG-HCN1 and stored for 48 h in ND96 solution in the absence
FIGURE 4 | Properties of heteromeric channels of WAG-HCN1 with HCN2. (A) Conductance-voltage relationship of rat HCN1 co-expressed with HCN2
stored in theophyllin-free solutions, recorded before (black squares) and after 5 min of application of 2 mM 8-Br-cAMP (open squares). (B) Conductance-voltage
relationship of WAG-HCN1 co-expressed with HCN2 stored in theophyllin-free solutions, recorded before (gray circles) and after 5 min of application of 2 mM
8-Br-cAMP (open circles). (C) V1/2 of activation for heteromeric channels of rat HCN1 or WAG-HCN1 co-expressed with HCN2. The number of experiments for
(A–C) are indicated in parenthesis within the panel (C). ∗p < 0.05.
Frontiers in Molecular Neuroscience | www.frontiersin.org 7 November 2015 | Volume 8 | Article 63
Wemhöner et al. N-terminal deleted HCN1 in WAG/Rij
FIGURE 5 | Molecular correlate for the WAG-HCN1 gain-of-function. (A) Cartoon depicting the N-termini of rat HCN1 (left) and WAG-HCN1 (right). The
N-terminus of rat HCN1 has a length of 135 amino acids. WAG-HCN1 has a deletion of 37 amino acids and a novel polyserine motif of six amino acids.
(B) Measurement of current amplitude of HCN1 and WAG-HCN1 48 h after injection and incubation in ND96 storage solution, supplemented with different protein
kinase inhibitors (1 μM bisindolylmaleimide (BIS), 1 μM H-89, 10 μM genistein, or 1 μM staurosporine). Currents were normalized to the HCN1 construct incubated
in normal storage solution. The number of experiments are indicated in the bar graphs. (C) Comparison of WAG-HCN1 (left) with a mutated WAG-HCN1
(HCN1-37-aa) where the polyserine motif has been mutated to the wild-type sequence GNSVCF (right). This construct harbors only the deletion and not the
polyserine stretch. (D) Current amplitudes of HCN1, WAG-HCN1 and HCN1-37-aa analyzed at −130 mV. HCN1-37-aa has a current amplitude similar to that of
rat HCN1 (0.88 ± 0.08). The number of experiments are indicated in the bar graphs. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
or presence of the kinase blockers. HCN1 and WAG-HCN1
showed a similar response to the kinase blockers (Figure 5B).
Both channels showed only minor changes in current amplitudes
by blockers of the PKA, PKC, and tyrosine kinases. Staurosporine
signiﬁcantly reduced HCN1 and WAG-HCN1 (Figure 5B),
while the current reduction was not signiﬁcantly diﬀerent for
HCN1 and WAG-HCN1 (p = 0.14). We therefore conclude
that the gain-of-function of WAG-HCN1 is not caused by an
altered phosphorylation at the WAG-HCN1-speciﬁc polyserine-
motif.
Gain-of-function of WAG-HCN1 Requires
the Replacement of the Native
N-terminal GNSVCF Sequence
To assess whether the deletion of the 37 amino acids or the
exchange of the subsequent GNSVCF sequence is responsible
for the WAG-HCN1 gain-of-function, we constructed a WAG-
HCN1 channel harboring only a deletion of 37 amino acids
(HCN1-37-aa), while the rat HCN1 sequence following the
deletion (GNSVCF) was not changed to polyserine (Figure 5C).
Next, we compared current amplitudes of HCN1, WAG-HCN1
and HCN137aa expressed in oocytes. TEVC recordings were
performed 2 days after injection of 5 ng of the respective
cRNAs (Figure 5D). While WAG-HCN1 showed a strong gain-
of-function, the HCN1-37-aa construct produced currents with
similar amplitudes as rat HCN1 (Figure 5D). Thus, the gain-of-
function of the WAG-HCN1 channel does not result from the 37
amino acid deletion alone, as it needs the amino acid exchanges
in the GNSVCF sequence. We propose that the deletion together
with the changes of this motif lead to a loss of retention of
the channels, presumably due to an impaired interaction with
another protein.
DISCUSSION
Based on mRNA analyses we here identiﬁed a variant of
rat HCN1 channels, termed WAG-HCN1, which was only
present in the thalamus of WAG/Rij rats ≥ P30. When
expressed alone in oocytes or co-expressed with other HCN
channel subtypes, WAG-HCN1 revealed a number of interesting
properties. In comparison to normal HCN1 the WAG variant
generated two-times more current and exerted also a positive
eﬀect when both variants were co-expressed. Co-expression
with other HCN channels subtypes (HCN2, HCN4), but
not Kv1.1 channels, resulted in reduced current amplitudes.
Furthermore, the co-expression of HCN2 with WAG-HCN1,
but not HCN1, abolished the modulation of the resulting
current by externally applied 8-Br-cAMP. Although the protein
expression of WAG-HCN1 channels in WAG/Rij rats was
not ultimately proven here, the present ﬁndings may help
to explain some aspects of the experimental observations
made with the WAG/Rij strain. This assumption may indeed
apply since early infantile epileptic syndromes and idiopathic
generalized epilepsy has been associated with mutations in
HCN1 and HCN2 channel genes (DiFrancesco and DiFrancesco,
2015).
Rats of the WAG/Rij strain serve as a well-established animal
model for absence epilepsy and changes in HCN1 properties
were previously proposed to contribute to the development of
seizures (Strauss et al., 2004; Budde et al., 2005; Schridde et al.,
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2006; Kole et al., 2007; Kanyshkova et al., 2012). Several groups
found changes in HCN1 properties, with a reduction or an
increase of HCN1, depending on the animal model and tissue
examined (Table 1). In the neocortex and hippocampus of the
WAG/Rij strain HCN1 is reduced on protein level but not the
mRNA level (Strauss et al., 2004). This reduction was proposed
to lead to an increased excitability of neurons in the SSC which
may facilitate the generation of SWDs and result in epileptic
seizures (Strauss et al., 2004; Kole et al., 2007). The hypothesis
that a parallel reduction of Ih in cortical and thalamic areas can
lead to absence epilepsies, is supported by the fact that genetic
and spontaneous HCN2 knock-out mouse develops spontaneous
absence seizures (Ludwig et al., 2003; Chung et al., 2009). In
contrast to data from the neocortex and hippocampus where
HCN1 seems to be down-regulated, increased hyperpolarization-
activated currents in the thalamocortical neurons are linked
to the generation of seizures (Di Pasquale et al., 1997; Budde
et al., 2005; Kuisle et al., 2006; Kanyshkova et al., 2012). We
reported an increased mRNA and protein expression of HCN1
in thalamocortical neurons of the WAG/Rij strain compared
to ACI rats, while the relative expression of other HCN family
members were not altered (Kanyshkova et al., 2012). Stronger
HCN1 expression correlated with an increased Ih current density
in WAG/Rij rats. These diﬀerences were ﬁrst detected between
P15 and P30 and peaked at P90. The latter age correlated with
the onset of absence epilepsies in these animals. These alterations
in HCN1were accompanied by a developmental up-regulation of
HCN2 and HCN4 in WAG/Rij and ACI rats, but no diﬀerences
between strains were found for the expression levels of these
two isoforms. Summarizing, in TC neurons of the WAG/Rij
strain the native Ih was characterized by an increased current
density, a negative shift in the activation curve, and a decreased
cAMP-sensitivity (Budde et al., 2005; Kanyshkova et al., 2012).
There was more TRIP8b protein detectable in TC neurons of
WAG/Rij versus ACI rats, which is in agreement with the more
hyperpolarized activation curves and reduced cAMP-sensitivity
of Ih in TC neurons of the WAG/Rij strain (Kanyshkova et al.,
2012).
In addition, theWAG-HCN1 variant which we have identiﬁed
here, may also help to explain further aspects of the experimental
observations made with the WAG/Rij strain in diﬀerent
brain regions (Table 1): (1) Our electrophysiological studies
revealed a gain-of-function for WAG-HCN1 without changes
in channel kinetics. This data is in good agreement with an
increased Ih current amplitude and faster activation kinetics of
thalamocortical Ih currents of theWAG/Rij strain. (2) TheWAG-
HCN1 variant forms heteromers with HCN1, HCN2, and HCN4.
While heteromeric channels with HCN1 have increased current
amplitudes, WAG-HCN1 suppresses heteromeric currents with
HCN2 and HCN4. The reduction of HCN2 and HCN4 which
have slower activation kinetics than HCN1 might contribute to
the faster activation kinetics observed in TC neurons of the
WAG/Rij strain. (3) Heteromeric channels of WAG-HCN1 with
HCN2 have a reduced cAMP sensitivity. This observation might
in part contribute to the complex changes in the cAMP-sensitivity
of Ih which was observed in TC neurons of the WAG/Rij
strain (Kanyshkova et al., 2012). (4) While WAG-HCN1 was
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not detected at P7, the WAG-HCN1 variant was up-regulated
at postnatal ages P30 and P90. These ﬁndings indicate that
the novel HCN1 channel variant appears in WAG/Rij rats
already at an age period where SWD are not yet present
(van Luijtelaar and Sitnikova, 2006), but the fate of the future
epileptic phenotype is critically determined by HCN expression
levels (Schridde et al., 2006; Blumenfeld et al., 2008). Most
importantly, the increased Ih current density in WAG/Rij
strains between P15 and P30, peaking at P90 is not caused
by an enhanced HCN1 transcription alone, but also by the
appearance of the novel WAG-HCN1 isoform in this time
window.
The conclusions discussed above are limited by the fact that
the expression of the WAG-HCN1 variant in the thalamus
was only determined on mRNA level in the present study.
We tried to overcome this limitation by generating four
monoclonal antibodies directed against overlapping fragments
of a short peptide containing the WAG-HCN1 polyserine motif
(SNSSSSSSSKVD; Abmart, Inc., Shanghai, China). However,
none of these antibodies was able to detect WAG-HCN1 protein
isolated from COS7 cells transfected with EGFP-tagged WAG-
HCN1 channels in Western blots (data not shown). Therefore,
the relative expression of WAG-HCN1 channels in the thalamus
on protein level currently remains unresolved.
Another open question is the mechanism of howWAG-HCN1
transcripts are generated in a tissue- and species-dependent
manner. The WAG-HCN1 is not generated by a classical
alternative splicing, as it lacks parts of the coding region in the
middle of the ﬁrst exon. However, as the genomic sequence of
WAG and ACI strains are identical, our data support a scenario
in WAG/Rij rats where not yet identiﬁed mechanisms lead to
post-transcriptional modiﬁcations of HCN1 and the generation
of WAG-HCN1.
It is known that HCN1, HCN2, and HCN4 channels remain
functional even after deletion of the CNBD or the entire
C-terminus (Wainger et al., 2001; Schulze-Bahr et al., 2003).
However, so far most of the data published indicates that
alteration or deletion of C-terminal portions of HCN channels
cause a decreased current expression and not a current increase.
However, our observation that the deletion of the proximal
part of the HCN1 N-terminus results in a current increase,
is supported by two studies in which an N-terminal deletion
in HCN1 leads to an increased current amplitude or surface
expression (Vemana et al., 2008; Pan et al., 2015). Vemana
et al. (2008) state: “The HCN1 channels had the COOH terminus
deleted and a small region in the NH2 terminus deleted that
maximize the expression in oocytes.” A recent study describes
a N-terminal ER export signal (20 amino acids) essential for
the targeting of HCN1 to the plasma membrane of the inner
segment of Xenopus photoreceptors (Pan et al., 2015). However,
this motif is not aﬀected in WAG-HCN1, as it is located shortly
after the deletion, starting at amino acid 75. Most importantly
within this study the localization of a series of N-terminal
truncation mutants of GFP-HCN1 were analyzed. Here it can
be noted that a WAG-like deletion of the ﬁrst 55 amino acids
of HCN1 results in a marked increase of ﬂuorescence at the
surface membrane (compare WT in Figure 2A versus 3B in Pan
et al., 2015). On the other hand the polyserine motif in WAG-
HCN1 channels appears to be of minor modulatory relevance,
as we did not observe an altered protein kinase regulation of the
WAG-HCN1 channel. However, the N-terminal deletion of the
37 amino acids alone cannot reproduce the electrophysiological
phenotype of the WAG-HCN1 channels. We found that the loss
of the GNSVCF wild-type sequence, directly following the 37
amino acid deletion, must contribute to the gain-of-function.
This could be based on at least two possible mechanisms. First,
a change in protein sequence could result in structural changes.
Second, a potential motif that retains HCN1 is deleted. Third,
the altered sequence might impair an interaction with a protein
binding to the N-terminus of the channel. A possible binding site
might include a part of the deleted sequence plus the GNSVCF
motif. The WAG-HCN1 might have an impaired interaction
with a protein involved in the channel traﬃcking, a structural
protein or a channel subunit. HCN1 channels have a proline-rich
N-terminus which is a putative interaction site for SH2-, SH3-,
or WW-domains (Kay et al., 2000). In addition, HCN1 channels
are known to interact with TRIP8b and Filamin A (Gravante
et al., 2004; Santoro et al., 2004). Filamin A causes a negative
shift in the voltage dependence of activation and causes reduction
in current amplitude (Gravante et al., 2004). Thus, the loss of
interaction with Filamin A could be a possible mechanism for
the current increase seen forWAG-HCN1.However, it would not
explain the negative shift in the voltage dependence observed for
heteromeric channels of WAG-HCN1 with HCN2. TRIP8b also
aﬀects HCN1 current amplitudes, but this eﬀect is dependent on
the isoform of TRIP8b (Santoro et al., 2004; Lewis et al., 2009;
Santoro et al., 2009; Zolles et al., 2009). Also with TRIP8b, the
voltage dependence of HCN1 is shifted to more hyperpolarized
potentials (Lewis et al., 2009; Santoro et al., 2009). Thus, also
a loss of interaction with TRIP8b cannot explain the eﬀects
observed with WAG-HCN1. In addition, both proteins, Filamin
A and TRIP8b interact with the C-terminus of HCN1, making
a loss-of-interaction with these proteins an unlikely mechanism.
Although one cannot completely rule out that strong changes
in the N-terminal sequence result in an altered stabilization
of a channel tetramer and their respective interaction partners.
Whether the eﬀects observed with WAG-HCN1 result from
a change in interaction with a known or unknown protein
partner or whether the eﬀects are based on structural changes in
the WAG-HCN1 constructs remains to be elucidated in future
studies. By using short deletions in HCN1 it may be possible
to elucidate the exact region which is gaining in the surface
expression of the channel and subsequently, the augmentation
of Ih.
The identiﬁcation of a WAG-HCN1 variant with a speciﬁc
gain-of-function and an impact on the biophysical properties
of heteromeric HCN channels raises many new questions and
prompts new biophysical studies in neuronal tissues of the
WAG/Rij strain. Future studies might focus for example on the
tissue speciﬁc expression of theWAG-HCN1 variant andwhether
this isoform also underlies a speciﬁc ontogenetic transcriptional
regulation. We conclude that the altered functional properties
of the WAG-HCN1 variant and the heteromeric channels with
WAG-HCN1 may help to explain many previous observations
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in native tissue of the WAG/Rij strain. In addition, the presence
of the novel WAG-HCN1 variant might represent one of several
factors for the epileptic phenotype of the WAG/Rij strain.
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